Data as of Q4 2025 (Dec 31, 2025)

BEONE MEDICINES LTD.

(ONC)

Financial Statements · SEC EDGAR XBRL

Revenue
$5.34B
+40.2%
Net Income
$286.9M
+144.5%
EPS
$0.19
+140.4%
Gross Margin
87.5%
Op. Income
$447.1M
+178.7%
FCF
$941.7M
+248.7%
Source: SEC EDGAR XBRL
Breakdown
Revenues
Revenues
Total Revenues
Cost of Revenues
Gross Profit
Operating Expenses & Income
Selling General & Admin
Research & Development
Operating Income
Non-Operating Income/Expense
Other Non-Operating Income
Pre-Tax Income
Income Tax Expense
Net Income
EPS (Basic)
EPS (Diluted)
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
$5.34B
$3.81B
$2.46B
$1.42B
$1.18B
$5.34B
$3.81B
$2.46B
$1.42B
$1.18B
-
-
-
$286.5M
$164.9M
$4.67B
$3.22B
$2.08B
$1.13B
$1.01B
$2.08B
$1.83B
$1.51B
$1.28B
$990.1M
$2.15B
$1.95B
$1.78B
$1.64B
$1.46B
$447.1M
-$568.2M
-$1.21B
-$1.79B
-$1.44B
-$42.6M
-$12.6M
$307.9M
-$223.9M
$15.9M
$416.9M
-$533.0M
-$825.8M
-$1.96B
-
$129.9M
$111.8M
$55.9M
$42.8M
$19.2M
$286.9M
-$644.8M
-$881.7M
-$2.00B
-$1.46B
$0.20
$-0.47
$-0.65
$-1.49
$-1.21
$0.19
$-0.47
$-0.65
$-1.49
$-1.21